Put companies on watchlist
Eckert & Ziegler Strahlen- und Medizintechnik AG
ISIN: DE0005659700
WKN: 565970
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Eckert & Ziegler Strahlen- und Medizintechnik AG · ISIN: DE0005659700 · EQS - Company News (122 News)
Country: Germany · Primary market: Germany · EQS NID: 1734847
28 September 2023 10:00AM

Eckert & Ziegler Receives Award for Professional Training


EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous
Eckert & Ziegler Receives Award for Professional Training

28.09.2023 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Berlin, September 28, 2023. Eckert & Ziegler AG has been awarded the Pankow 2023 Training Prize for outstanding training quality. The award was presented yesterday at a celebration event by Berlin-Pankow District Mayor Dr. Cordelia Koch.

The jury justified the award with the great commitment to professional training and the special training concept of Eckert & Ziegler AG. The strong cohesion within the trainee team, the individual support of trainees according to their skills and abilities, and the numerous opportunities to be taken on by the Eckert & Ziegler Group after completing their training were also highlighted.

"We are delighted to have received this award for outstanding quality and continuity in training. At the same time, we are full of thanks to all employees involved in training, who have more than earned this award," explains Dr. Harald Hasselmann, Chairman of the Executive Board of Eckert & Ziegler AG and responsible for Human Resources. "I would also like to thank our dedicated trainees, who are the professionals of tomorrow."

Eckert & Ziegler regularly trains industrial clerks, IT specialists for system integration, and chemical laboratory assistants. Training starts on September 1 of each year. Applications are gladly accepted at any time.The Berlin-Pankow Training Prize is awarded annually as part of the Pankow Training Initiative to particularly committed training companies in the Pankow district. Companies can be nominated for the award or apply themselves in four competition categories, sorted by company size. Eckert & Ziegler receives the Pankow 2023 Training Award in the category with over 50 employees.

About Eckert & Ziegler.
Eckert & Ziegler Strahlen- und Medizintechnik AG with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the SDAX index of Deutsche Börse.
Contributing to saving lives.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com 



28.09.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX,
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1734847

 
End of News EQS News Service

1734847  28.09.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1734847&application_name=news&site_id=boersengefluester
Visual performance / price development - Eckert & Ziegler Strahlen- und Medizintechnik AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.